🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Primary Membranous Nephropathy

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites📍 Little Rock📍 Tustin📍 Gainesville Nkarta, Inc. · Tests: NKX019, Fludarabine, Cyclophosphamide A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy NCT05668403Phase 16 sites📍 Zhengzhou📍 Shijiazhuang📍 Hangzhou Shanghai Jiaolian Drug Research and Development Co., Ltd · Tests: B007, B007, B007 OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) NCT06781944Phase 31 site📍 Shanghai Huashan Hospital · Tests: Obinutuzumab, CTX combined with Glucocorticoids Study of YK012 in Primary Membranous Nephropathy NCT06982729Phase 11 site📍 Beijing Excyte Biopharma Ltd · Tests: YK012 Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy NCT07861204Phase 2, Phase 31 site📍 Beijing Peking University First Hospital · Tests: Rituximab combined with cyclosporine, rituximab A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy NCT07096843Phase 238 sites📍 Denver📍 Orlando📍 Atlanta Climb Bio, Inc. · Tests: budoprutug A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) NCT06962800Phase 3114 sites📍 Huntsville📍 Fresno📍 Los Angeles Biogen · Tests: Felzartamab, Tacrolimus, Standard of Care IST A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy NCT05696613Phase 331 sites📍 Los Angeles📍 San Dimas📍 Tarzana Cerium Pharmaceuticals, Inc. · Tests: SNP-ACTH (1-39) Gel, Rituximab Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) NCT07157787Phase 240 sites📍 Loma Linda📍 San Diego📍 Minneapolis Alexion Pharmaceuticals, Inc. · Tests: ALXN1920, Placebo A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease NCT07571746Phase 227 sites📍 Los Angeles📍 Los Angeles📍 Iowa City AstraZeneca · Tests: Surovatamig Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites📍 Los Angeles📍 Denver📍 Tamarac Walden Biosciences · Tests: WAL0921, Placebo Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) NCT07204275Phase 2, Phase 3115 sites📍 Montgomery📍 Surprise📍 Los Angeles Vertex Pharmaceuticals Incorporated · Tests: Povetacicept, Tacrolimus A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy NCT07851220Phase 34 sites📍 Los Angeles📍 Doral📍 Miami Amgen · Tests: Inebilizumab, Tacrolimus A Real World Study About PMN NCT06893328n/a1 site📍 Guangzhou Wei Chen Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy NCT07289763Phase 21 site📍 Nanjing Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy NCT06573411Phase 41 site📍 Guangzhou First Affiliated Hospital, Sun Yat-Sen University · Tests: ACEI/ARB+ finerenone, ACEI/ARB An Outcome Analysis of Primary Membranous Nephropathy NCT06242327n/a2 sites📍 Bergamo📍 Ranica Mario Negri Institute for Pharmacological Research Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy NCT05514015Phase 41 site📍 Guangzhou First Affiliated Hospital, Sun Yat-Sen University · Tests: rituximab combined with corticosteroids, rituximab Atacicept in Multiple Glomerular Diseases NCT06983028Phase 21 site📍 Brisbane Vera Therapeutics, Inc. · Tests: Atacicept National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association Belimumab With Rituximab for Primary Membranous Nephropathy NCT03949855Phase 220 sites📍 Birmingham📍 Little Rock📍 San Francisco National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Belimumab, Placebo for Belimumab, Rituximab A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. NCT06470191Phase 2, Phase 321 sites📍 Beijing📍 Beijing📍 Changchun Shanghai Jiaolian Drug Research and Development Co., Ltd · Tests: B007, Cyclosporin Capsules
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy